LOGC LogicBio Therapeutics, Inc.

OTC
$14.87

LogicBio Therapeutics, Inc. (LOGC) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

30D 90D 6M 1Y
Insider signal Bullish Insiders bought more than they sold over this window — uncommon at any size.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 0 sellers in the last 90 days
Insiders buying
3
13 transactions
Insiders selling
0
0 transactions
Purchases
$3.8M
428,248 shares
Sales
$0
0 shares
Net activity
$3.8M
purchases less sales

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: June 12, 2026 , by Stewart Scott Matthew .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Stewart Scott Matthew CFO & COO Buy 10,000 $9.76 $97.6K 60,000
LEVY PAUL S Director Buy 12,926 $9.17 $118.5K 638,112
LEVY PAUL S Director Buy 63,019 $9.06 $571.2K 625,186
LEVY PAUL S Director Buy 1,000 $9.04 $9.0K 562,167
LEVY PAUL S Director Buy 35,409 $9.02 $319.4K 561,167
LEVY PAUL S Director Buy 18,981 $9.05 $171.8K 525,758
LEVY PAUL S Director Buy 6,712 $9.02 $60.6K 506,777
Bobbili Raja Director Buy 92,918 $8.75 $812.7K 630,201
Bobbili Raja Director Buy 4,862 $8.75 $42.5K 537,283
Bobbili Raja Director Buy 32,421 $8.62 $279.6K 532,421
Bobbili Raja Director Buy 45,430 $8.69 $394.7K 500,000
Bobbili Raja Director Buy 87,295 $8.77 $765.3K 454,570
Bobbili Raja Director Buy 17,275 $8.74 $150.9K 367,275

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.